Results 51 to 60 of about 3,878,916 (126)
In this retrospective study, the clinical characteristics of 146 patients diagnosed with fixed drug eruption (FDE) in a tertiary hospital in Southern Taiwan were analyzed.
Jui-Wen Yeh, Wei-Ting Liu
doaj +1 more source
ABSTRACT The present guideline updates the initial ESCD patch testing guideline, summarizing all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions
Wolfgang Uter +23 more
wiley +1 more source
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda +31 more
wiley +1 more source
Generalized fixed drug eruption to piperacillin/tazobactam and review of literature [PDF]
Fixed drug eruption (FDE) is an adverse drug reaction characterized by the development of well-circumscribed, round, dusky erythematous macules and plaques on cutaneous or mucosal surfaces.
Konia, Thomas +10 more
core +1 more source
ABSTRACT Background and Aims Stevens‐Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme major (EM major) are severe dermatologic conditions characterized by varying degrees of skin detachment and involvement of mucosal membranes, often triggered by drug reactions or infections.
Sadaf Salehi +6 more
wiley +1 more source
Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek +3 more
wiley +1 more source
Two cases of generalized bullous fixed-drug eruption triggered by etodolac
Işıl Göğem İmren +5 more
doaj +1 more source
Wells syndrome: clinical findings and treatment management in a large cohort of 48 patients
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa +8 more
wiley +1 more source
A Multifaceted Holistic Review of the Literature on Scar Dermatoses
ABSTRACT Many cutaneous diseases originate or manifest in scars. Scars are areas of compromised skin, which renders them a vulnerable cutaneous district for diseases to develop. The pathophysiology explaining why some dermatoses grow in scars is not yet thoroughly explored. The present study reviews the present literature on scar dermatoses.
Dana Maria Khoury +5 more
wiley +1 more source
A CASE OF TENOXICAM INDUCED GENERALIZED (MULTIFOCAL) BULLOUS FIXED DRUG ERUPTION
Fixed drug eruption is a common cutaneus reaction characterized by the formation of localized erytema, hyperpigmentation and blisters that recur at the same cutaneous site or sites each time when the drug is ingested. Rarely it can be disseminated. Fixed
Arican, Ozer, Urun, Mustafa
core +1 more source

